Clinical trial

Low Dose Apomorphine and Parkinsonism

NCT00472355 · Oregon Health and Science University, Other · Withdrawn

Key facts

NCT number NCT00472355
Title Low Dose Apomorphine and Parkinsonism
Official title Does Presynaptic Dopamine Receptor Stimulation Transiently Worsen Parkinsonism?
Lead sponsor Oregon Health and Science University, Other
Collaborators National Institute of Neurological Disorders and Stroke (NINDS) NIH
Status Withdrawn
Phase Phase 2
Study type Interventional
Conditions Parkinson's Disease
Intervention type Drug
Interventions apomorphine
Enrollment 0
Start date Oct 1, 2005
Primary completion May 1, 2007
Completion May 1, 2007
First posted May 11, 2007
Last update posted Nov 29, 2018
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies